Multicenter Pharmacokinetic Study of Pembrolizumab for Non-Small Cell Lung Cancer in Older Adults Aged Over 75 Years

被引：0

作者：

Horinouchi, H. ^{[1
]}

Ohe, Y. ^{[1
]}

Yamanaka, Y. ^{[2
]}

Kurata, T. ^{[2
]}

Watanabe, K. ^{[3
]}

Hosomi, Y. ^{[3
]}

Nakahara, Y. ^{[4
]}

Asao, T. ^{[5
]}

Saeki, S. ^{[6
]}

Tsubata, Y. ^{[7
]}

Fujita, Y. ^{[8
]}

Konishi, J. S. ^{[9
]}

Mizugaki, H. ^{[10
]}

Ohuchi, M. ^{[11
]}

Yagishita, S. ^{[11
]}

Hamada, A. ^{[11
]}

机构：

[1] Natl Canc Ctr, Tokyo, Japan

[2] Kansai Med Univ Hosp, Osaka, Japan

[3] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan

[4] Kitasato Univ, Sch Med, Sagamihara, Kanagawa, Japan

[5] Juntendo Univ Hosp, Tokyo, Japan

[6] Kumamoto Univ Hosp, Kumamoto, Japan

[7] Shimane Univ, Fac Med, Matsue, Shimane, Japan

[8] Jikei Univ, Sch Med, Tokyo, Japan

[9] Hokkaido Univ, Fac Med, Sapporo, Hokkaido, Japan

[10] JFCR, Canc Inst Hosp, Tokyo, Japan

[11] Natl Canc Ctr, Res Inst, Tokyo, Japan

来源：

JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期

关键词：

Pembrolizumab; pharmacokinetics; Elderly;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EP11.03-08

引用

页码：S622 / S622

页数：1

共 50 条

[41] Neoadjuvant Pembrolizumab for Early Stage Non-Small Cell Lung Cancer
Bar, J.
Urban, D.
Redinsky, I.
Ackerstein, A.
Daher, S.
Kamer, I.
Onn, A.
Shulimzon, T.
Peled, M.
Zeitlin, N.
Kremer, R.
Raskin, S.
Ben-Nun, A.
Perelman, M.
Ofek, E.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S865 - S866
[42] The role of pembrolizumab in the treatment of advanced non-small cell lung cancer
Santabarbara, Giuseppe
Maione, Paolo
Rossi, Antonio
Palazzolo, Giovanni
Gridelli, Cesare
ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (11)
[43] An audit of pembrolizumab use in non-small cell lung cancer in Nottingham
Suyanto, S.
Yeo, D.
Khan, S.
LUNG CANCER, 2018, 115 : S39 - S39
[44] Barriers to non-small cell lung cancer clinical trial accrual for older adults
Hardesty, J. J.
Zellars, R. C.
Kanarek, N. F.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2014, 62 : S125 - S125
[45] The efficacy and onset risk of interstitial lung disease of nivolumab in elderly (75 years old or older) patients with non-small cell lung cancer
Tamiya, A.
Tamiya, M.
Nakahama, K.
Taniguchi, Y.
Shiroyama, T.
Isa, S-I.
Inoue, T.
Okishio, K.
Nishino, K.
Kumagai, T.
Suzuki, H.
Hirashima, T.
Imamura, F.
Atagi, S.
ANNALS OF ONCOLOGY, 2017, 28
[46] Long-term results of surgical treatment of non-small cell lung cancer in patients over 75 years of age
Pawlak, Krystian
Gabryel, Piotr
Kujawska, Anna
Kasprzyk, Mariusz
Piwkowski, Cezary
Kuffel, Blazej
Dyszkiewicz, Wojciech
KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA, 2018, 15 (02): : 65 - 71
[47] Population-based patterns of treatment and survival for patients with stage I and II non-small cell lung cancer aged 65-74 years and 75 years or older
Driessen, Elisabeth
Detillon, Deniece
Bootsma, Gerbern
De Ruysscher, Dirk
Veen, Eelco
Aarts, Mieke
Janssen-Heijnen, Maryska
JOURNAL OF GERIATRIC ONCOLOGY, 2019, 10 (04) : 547 - 554
[48] Is Surgical Resection a Safe and Effective Treatment for Non-Small Cell Lung Cancer Patients over 75-Years-Old?
Ogawa, Fumihiro
Wang Guoqin
Hoshi, Keiko
Matsui, Yoshio
Amano, Hideki
Kurohzu, Naomi
Hara, Hidenori
Nezu, Kenji
Iyoda, Akira
Satoh, Yukitoshi
JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S405 - S405
[49] Survival and Treatment Pattern of Non-small Cell Lung Cancer Over 20 Years
Pitz, Marshall W.
Musto, Grace
Demers, Alain A.
Kliewer, Erich V.
Navaratnam, Srisala
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (04) : 492 - 498
[50] Efficacy and Safety of Pembrolizumab in Non-Small Cell Lung Cancer in Our Institution: A Retrospective Study
Saijo, N.
Inagaki, Y.
Abe, Y.
Kono, S.
Taniguchi, Y.
Otsuka, K.
Naoki, Y.
Tamiya, A.
Okishio, K.
Atagi, S.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S900 - S900

← 1 2 3 4 5 →